Document Detail


Antibiotics that inhibit fungal cell wall development.
MedLine Citation:
PMID:  7826015     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The discovery of antifungal agents that possess selective toxicity against the eukaryotic fungal cell remains an important scientific challenge. The growing medical need for safe and effective antifungal agents stems from the rapidly increasing population of immunocompromised patients. Although the treatment of fungal infections is progressing steadily, currently available agents act on targets that are also found in mammalian cells. Ideally, a selectively toxic antifungal agent should be developed that interacts with a fungal target not found in other eukaryotic cells. This strategy involves selective inhibition of the biosynthesis of important structural elements in the fungal cell. The fungal cell wall is such a therapeutic target. In addition, antibiotics have been discovered that inhibit the development of the fungal cell. The major targets are glucan synthesis, inhibited by the echinocandin lipopeptides and the papulacandins; chitin synthesis, inhibited by the polyoxins and nikkomycins; and mannan, to which the pradimicins selectively bind. The extensively studied echinocandin lipopeptides are fungicidal agents with low toxicity, and one member, cilofungin--a semisynthetic analogue of echinocandin B--has been tested in the clinic. Newer echinocandins, such as LY303366 and the pneumocandins, have excellent activity against yeasts and Pneumocystis carinii infections in animals and show promise as potential clinical antifungal candidates. Chitin synthase inhibitors have been studied through chemical modification of the polyoxins and nikkomycins but are limited because of unfavorable pharmacokinetics. The pradimicins show the ability to bind mannan and thus exert an antifungal effect. The mode of action of this class of inhibitors is not fully understood, but their unique action may provide a better understanding of mannan as a target.
Authors:
M Debono; R S Gordee
Related Documents :
893555 - Differentiation of the tapetum in avena. i. the cell surface.
7152675 - Stimulation of migration of human monocytes by bacterial cell walls and muramyl peptides.
20013255 - The putative bacillus subtilis l,d-transpeptidase ycib is a lipoprotein that localizes ...
16659245 - Correlative studies of cell wall enzymes and growth.
689255 - Electronmicroscopical and electrophysiological investigations on polyethylene glycol in...
7860145 - Somatostatin analog rc-160 inhibits growth of cfpac-1 human pancreatic cancer cells in ...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Annual review of microbiology     Volume:  48     ISSN:  0066-4227     ISO Abbreviation:  Annu. Rev. Microbiol.     Publication Date:  1994  
Date Detail:
Created Date:  1995-02-16     Completed Date:  1995-02-16     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0372370     Medline TA:  Annu Rev Microbiol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  471-97     Citation Subset:  IM    
Affiliation:
Natural Products Research Division, Eli Lilly and Company, Indianapolis, Indiana 46285.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antifungal Agents / chemistry,  pharmacology*
Cell Wall / drug effects*
Chitin Synthase / antagonists & inhibitors
Fungi / drug effects*
Glucosyltransferases / antagonists & inhibitors
Mannans / metabolism
Chemical
Reg. No./Substance:
0/Antifungal Agents; 0/Mannans; EC 2.4.1.-/Glucosyltransferases; EC 2.4.1.-/glucan synthase; EC 2.4.1.16/Chitin Synthase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The role of pH and temperature in the development of Leishmania parasites.
Next Document:  Structural and functional properties of Trypanosoma trans-sialidase.